跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要研究随机试验处理效应的协变量调整、加权与增广估计,直接对应因果推断。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Baoshan Zhang
Yi Chen
Yu Du
Tuo Wang

生存结局协变量调整中平衡加权与增广方法的联系

研究问题
在随机临床试验的生存结局分析中,平衡加权与增广调整能否针对相同的边际检验及效应目标,并获得一致的效率收益?
方法与思路
作者发展校准权重和倾向评分权重,分析其与增广 log-rank 得分及边际 Cox 得分根的一阶等价性,并讨论方差估计。
材料陈述的贡献
摘要称满足平衡正则条件的加权程序与增广方法一阶等价,并继承其有效性和效率收益,同时提出防范有限样本一类错误膨胀的建议。
阅读关注点
应核对平衡正则条件、边际风险比的具体目标、删失处理方式,以及方差估计建议如何适配不同权重和有限样本情形。
阅读边界
这是 arXiv 预印本,同行评审与期刊接收未核实;摘要未列明等价性与效率保证的完整条件,一阶等价也不保证有限样本结果相同。

原文摘要

Covariate adjustment improves the efficiency of treatment-effect analyses in randomized clinical trials, provided the adjustment targets the correct quantity. For time-to-event endpoints, two marginal targets are of primary interest: the log-rank test for the presence of a treatment effect and the marginal hazard ratio for its magnitude. Existing covariate adjustment approaches reach these targets by different ways. Augmentation adjusts the log-rank score by regressing derived outcomes on the baseline covariates within each arm. Weighting instead reweights the two arms to balance the covariates before the survival comparison is formed: inverse probability weighting does so through a fitted propensity model, while calibration weighting solves directly for weights that match covariate means. In this manuscript, we first develop balancing weighting for time-to-event endpoints, covering both calibration weights (stable balancing weights and entropy balancing) and propensity score weights, and prove that any balancing-regular weighting is first-order equivalent to the augmented log-rank score and to the root of the marginal Cox score. All three routes therefore deliver the same estimator to first order, and calibration reaches it without fitting any model. The weighted procedures thereby inherit the validity and guaranteed efficiency gain of the augmentation approach. In addition, we show that the efficiency gain grows with the prognostic strength of the adjustment covariates, while the practical caveat lies in variance estimation, for which we give recommendations to guard against finite-sample Type I error inflation. We further confirm our results through simulation studies and an analysis of the REWIND cardiovascular trial.

笔记与分组
相关领域论文